Brett Wattles
The Latest
-
Scientists Behind AI Breakthrough in Protein Structure Prediction Win Nobel Prize in Chemistry
The Royal Swedish Academy of Sciences awarded the 2024 Nobel Prize in Chemistry on Wednesday to three scientists whose work using artificial intelligence has revolutionized the prediction and design of protein structures, addressing one of biology's most enduring challenges. 
The Royal Swedish Academy of Sciences awarded the 2024 Nobel Prize in Chemistry on Wednesday to three scientists whose work using artificial intelligence has revolutionized the prediction and design of protein structures, addressing one of biology's most enduring challenges. -
Nobel Prize in Physics Awarded for AI Breakthroughs That Revolutionized Technology
Two pioneering scientists, John J. Hopfield and Geoffrey E. Hinton, have been awarded the Nobel Prize in Physics for their transformative work in artificial intelligence (AI), which laid the foundations for the field of machine learning. The Royal Swedish Academy of Sciences announced the accolade on Tuesday, highlighting the duo's contributions that have revolutionized not only technology but also research across multiple scientific domains. 
Two pioneering scientists, John J. Hopfield and Geoffrey E. Hinton, have been awarded the Nobel Prize in Physics for their transformative work in artificial intelligence (AI), which laid the foundations for the field of machine learning. The Royal Swedish Academy of Sciences announced the accolade on Tuesday, highlighting the duo's contributions that have revolutionized not only technology but also research across multiple scientific domains. -
American Biologists Victor Ambros and Gary Ruvkun Win Nobel Prize for Discovery of MicroRNA
The 2024 Nobel Prize in Physiology or Medicine has been awarded to American biologists Victor Ambros and Gary Ruvkun for their transformative discovery of microRNA, a critical element in the regulation of gene activity. This groundbreaking research has provided new insights into the mechanisms that govern how genes control the formation and specialization of different cell types within the human body. 
The 2024 Nobel Prize in Physiology or Medicine has been awarded to American biologists Victor Ambros and Gary Ruvkun for their transformative discovery of microRNA, a critical element in the regulation of gene activity. This groundbreaking research has provided new insights into the mechanisms that govern how genes control the formation and specialization of different cell types within the human body. -
Congo Begins Mpox Vaccination Campaign After 859 Deaths
In a crucial move to combat the escalating mpox outbreak, authorities in the Democratic Republic of Congo (DRC) have launched the country's first vaccination campaign against the virus, which has claimed the lives of 859 people this year. With more than 30,000 suspected cases, the DRC remains the epicenter of the outbreak, accounting for 80% of Africa's total cases. 
In a crucial move to combat the escalating mpox outbreak, authorities in the Democratic Republic of Congo (DRC) have launched the country's first vaccination campaign against the virus, which has claimed the lives of 859 people this year. With more than 30,000 suspected cases, the DRC remains the epicenter of the outbreak, accounting for 80% of Africa's total cases. -
FDA Approves Bristol Myers Squibb’s Cobenfy, First Novel Schizophrenia Drug in 70 Years
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking schizophrenia treatment, Cobenfy, marking the first novel approach to treating the disorder in over 70 years. Unlike traditional antipsychotic medications that target dopamine receptors, Cobenfy utilizes a combination of xanomeline, which activates muscarinic receptors in the brain, and trospium, which minimizes the gastrointestinal side effects commonly associated with xanomeline. 
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking schizophrenia treatment, Cobenfy, marking the first novel approach to treating the disorder in over 70 years. Unlike traditional antipsychotic medications that target dopamine receptors, Cobenfy utilizes a combination of xanomeline, which activates muscarinic receptors in the brain, and trospium, which minimizes the gastrointestinal side effects commonly associated with xanomeline. -
Free COVID-19 Tests Available Again as U.S. Prepares for Winter Surge
Americans can once again order free at-home COVID-19 tests from the federal government as the Biden administration seeks to prepare for the upcoming respiratory virus season. 
Americans can once again order free at-home COVID-19 tests from the federal government as the Biden administration seeks to prepare for the upcoming respiratory virus season. -
U.S. Obesity Rates Stabilize, but Severe Obesity Rises, CDC Reports
For the first time in over a decade, the rate of obesity among U.S. adults has leveled off, according to new data from the Centers for Disease Control and Prevention (CDC). However, while the general obesity rate has shown a slight decline, the rate of severe obesity continues to rise, raising significant concerns about the long-term health implications for Americans. 
For the first time in over a decade, the rate of obesity among U.S. adults has leveled off, according to new data from the Centers for Disease Control and Prevention (CDC). However, while the general obesity rate has shown a slight decline, the rate of severe obesity continues to rise, raising significant concerns about the long-term health implications for Americans. -
Whooping Cough Cases Surge Nationwide: Highest Levels in Nearly a Decade
The United States is experiencing a significant resurgence of whooping cough cases, with infection rates reaching the highest levels seen in nearly a decade. The Centers for Disease Control and Prevention (CDC) reported Thursday that pertussis cases, commonly known as whooping cough, are climbing rapidly across the country, particularly as students return to school. 
The United States is experiencing a significant resurgence of whooping cough cases, with infection rates reaching the highest levels seen in nearly a decade. The Centers for Disease Control and Prevention (CDC) reported Thursday that pertussis cases, commonly known as whooping cough, are climbing rapidly across the country, particularly as students return to school. -
New COVID Variant XEC Spreads Across U.S. and Europe, but Health Officials Urge Calm
A new COVID-19 variant, known as XEC, is spreading across the United States and Europe, drawing attention from health officials and researchers as they monitor its growth ahead of the winter season. The variant has already been detected in at least 25 U.S. states, with New Jersey, California, and Virginia reporting the highest number of cases. Labs in these states have confirmed over 100 infections, though the exact impact of this new strain remains uncertain. 
A new COVID-19 variant, known as XEC, is spreading across the United States and Europe, drawing attention from health officials and researchers as they monitor its growth ahead of the winter season. The variant has already been detected in at least 25 U.S. states, with New Jersey, California, and Virginia reporting the highest number of cases. Labs in these states have confirmed over 100 infections, though the exact impact of this new strain remains uncertain. -
First U.S. Human Case of Bird Flu Without Animal Contact Raises Concerns Among Health Officials
U.S. health officials have confirmed a new case of bird flu in a Missouri resident, marking the first instance in the country where the virus has been detected in a human with no known contact with animals. 
U.S. health officials have confirmed a new case of bird flu in a Missouri resident, marking the first instance in the country where the virus has been detected in a human with no known contact with animals.
